Hypofractionated Stereotactic Radiotherapy for Primary and Secondary Intrapulmonary Tumors: First Results of a Phase I/II Study

PURPOSE: To evaluate the feasibility, efficacy, and side effects of dose escalation in hypofractionated stereotactic radiotherapy (hfSRT) for intrapulmonary tumors with the Novalis™ system (BrainLAB AG, Heimstetten, Germany). PATIENTS AND METHODS: From 07/2003 to 01/2005, 21 patients/39 tumors were...

Descripción completa

Detalles Bibliográficos
Autores principales: Ernst-Stecken, Antje, Lambrecht, Ulrike, Mueller, Reinhold, Sauer, Rolf, Grabenbauer, Gerhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Urban & Vogel 2006
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3233368/
https://www.ncbi.nlm.nih.gov/pubmed/17149575
http://dx.doi.org/10.1007/s00066-006-1577-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3233368/
https://www.ncbi.nlm.nih.gov/pubmed/17149575
http://dx.doi.org/10.1007/s00066-006-1577-x

Ejemplares similares